Gattex approved for short bowel syndrome
(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.
Dec 22, 2012
1
0
(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.
Dec 22, 2012
1
0
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Dec 17, 2012
0
0
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Dec 16, 2012
0
0
(Medical Xpress)—Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a University at Buffalo professor ...
Dec 10, 2012
0
0
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0
A new study of working women has identified factors during pregnancy and postpartum that can predict pain in the joints that comprise the pelvic girdle. While 90 percent of working women in the Netherlands return to work ...
Dec 4, 2012
0
0
(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.
Nov 29, 2012
0
0
(Medical Xpress)—Blasting superbugs with tiny nano-sized antibiotics delivered via powder aerosol may be a faster, safer and cheaper way of treating respiratory infectious diseases such as pneumonia or cystic fibrosis, ...
Nov 29, 2012
0
0
Three quarters of pregnant women take sick leave from work but employers can help reduce this through flexible work adjustments, suggests a new study published today (7 November) in BJOG: An International Journal of Obstetrics ...
Nov 7, 2012
0
0
(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).
Oct 26, 2012
0
0